An open-label trial of memantine in treatment-resistant obsessive-compulsive disorder

BACKGROUND: Obsessive-compulsive disorder (OCD) is often refractory to treatment. Glutamatergic neurotransmission modulating agents like memantine, an N-methyl-D-aspartate receptor open channel blocker (antagonist), has been reported to be beneficial in OCD. MATERIALS AND METHODS: Twelve subjects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakhla, Ajay Kumar, Verma, Vijay, Soren, Subhas, Sarkhel, Sujit, Chaudhury, Suprakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085808/
https://www.ncbi.nlm.nih.gov/pubmed/25013317
http://dx.doi.org/10.4103/0972-6748.132930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085808/
https://www.ncbi.nlm.nih.gov/pubmed/25013317
http://dx.doi.org/10.4103/0972-6748.132930

Ejemplares similares